Company Filing History:
Years Active: 2018-2019
Title: The Innovations of Lieven Elvire Colett Baert
Introduction
Lieven Elvire Colett Baert is a notable inventor based in Bruges, Belgium. He has made significant contributions to the field of medical formulations, particularly in the treatment of upper respiratory tract infections. With a total of 2 patents to his name, Baert's work is recognized for its potential impact on public health.
Latest Patents
Baert's latest patents focus on polyinosinic-polycytidylic acid (poly (I:C)) formulations. These formulations are designed for the treatment of upper respiratory tract infections. The invention involves a composition comprising micro particles of polyinosinic-polycytidylic acid and a carrier polymer selected from starch, alginate, blanose, or DPPC (dipalmitoylphosphatidylcholine). This composition is intended for use in preventing and/or treating viral infections of the upper respiratory tract or the common cold. Additionally, a device, preferably a nasal delivery system, is included for use by patients in need of prevention or treatment.
Career Highlights
Lieven Elvire Colett Baert is currently associated with Janssen Sciences Ireland UC. His work at this company has allowed him to focus on innovative solutions in the pharmaceutical industry. His contributions are aimed at enhancing the effectiveness of treatments for viral infections.
Collaborations
Baert has collaborated with notable colleagues in his field, including Bruce Albert Malcolm and Roger Paulus Maria Sutmuller. These collaborations have likely enriched his research and development efforts, leading to advancements in his patented technologies.
Conclusion
Lieven Elvire Colett Baert is a distinguished inventor whose work in polyinosinic-polycytidylic acid formulations holds promise for improving treatments for upper respiratory infections. His contributions to the field are significant and reflect a commitment to innovation in healthcare.